Efficacy and Safety of Autologous Stem Cell Transplantation in First-Line Treatment and at Relapse in Elderly Patients with Multiple Myeloma
Our analysis shows that HDT/ASCT is safe and effective in eligible elderly MM patients in first-line treatment and at relapse. A careful patient selection according to biological rather than chronological age is of crucial importance.
Authors
- Axel Benner (ORCID: https://orcid.org/0000-0002-7238-6956)
- Niels Weinhold (ORCID: https://orcid.org/0000-0002-5464-3234)
- Eva-Maria Klein
- Hartmut Goldschmidt (ORCID: https://orcid.org/0000-0003-0961-0035)
- Uta Bertsch (ORCID: https://orcid.org/0000-0001-5584-3951)
- Sandra Sauer (ORCID: https://orcid.org/0000-0001-5552-3149)
- Kaya Miah (ORCID: https://orcid.org/0000-0002-0265-3529)
- Maximilian Merz (ORCID: https://orcid.org/0000-0001-8513-4240)
- Sejla Hujic
Institutions
- German Cancer Research Center (DE)
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- Nuremberg Hospital (DE)
- National Center for Tumor Diseases (DE)
- University Hospital Leipzig (DE)
- Schwetzingen Technical Institute & Graduate Court Registrars' College (DE)
Publication Details
- Journal
- Oncology
- Published
- 2024-10-03
- DOI
- https://doi.org/10.1159/000541541
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00